Franklyn Health was proud to attend WHX Dubai 2026, one of the largest and most influential healthcare and MedTech events in the world. Representing the company, Rob Bedford and Michael Branagan-Harris spent the event connecting with clients, partners and consultants from across the global medical technology and life sciences community.
WHX Dubai brings together healthcare leaders, innovators, and decision-makers from around the world, making it a key destination for companies operating at the forefront of MedTech, medical devices, and diagnostics. For Franklyn Health, it offered another valuable opportunity to deepen international relationships and stay close to the latest advances shaping the future of healthcare.
Meeting Clients and Partners on the Global Stage
Throughout the event, Rob and Michael met with a wide range of clients, partners, and industry consultants — reflecting the breadth of Franklyn Health’s growing international network. These conversations reinforced the company’s role as a trusted MedTech clinical research and regulatory partner for organisations across multiple markets and regions.
As Franklyn Health continues to expand its presence at major industry events worldwide, gatherings like WHX Dubai play an important part in maintaining strong, ongoing relationships with the clients and collaborators who rely on its expertise in clinical strategy, regulatory affairs, and market access.
Discovering the Latest in MedTech Innovation
WHX Dubai 2026 also offered a front-row view of some of the most exciting emerging technologies in the sector. Rob and Michael saw a wealth of cutting-edge MedTech, medical device, and diagnostics innovation on display — a reminder of the pace of change across the global healthcare landscape and the importance of staying connected to it.
Engaging directly with new technologies and the teams behind them helps Franklyn Health remain at the leading edge of MedTech clinical research, ensuring the company can continue to guide ambitious device and diagnostics manufacturers through development, regulatory pathways, and market access.
A Global Partner for Emerging MedTech
Franklyn Health is purpose-built to partner with ambitious medical device and diagnostics manufacturers, helping them develop clinical strategy, solve complex regulatory challenges, and bring new technologies to market, faster.
Franklyn Health’s presence at WHX Dubai 2026 was the latest in an ongoing programme of international industry engagements — reinforcing its reputation as a globally connected, highly skilled, and increasingly in-demand leader in MedTech clinical research, regulatory strategy, and market access.
Are you a MedTech company looking for a CRO that understands your product, your pace, and your purpose?
Partner with Franklyn Health, where expertise meets agility, and your innovation becomes our mission.
Contact us to discuss your next medical device or diagnostic clinical study.
